Figure 1.
Flow diagram of randomized patients with relapsed or refractory multiple myeloma who were enrolled in the JCOG0904 study comparing bortezomib plus dexamethasone (BD) vs thalidomide plus dexamethasone (TD)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.